Updated: GSK and Flagship to create up to 10 vaccines, medicines across respiratory and immunology

GSK and Flag­ship Pi­o­neer­ing will joint­ly pay up to $150 mil­lion to kick-start a res­pi­ra­to­ry and im­munol­o­gy tie-up.

The pair will cre­ate new vac­cines and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.